Evidence map›Paper›PMID 37171483›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2023

Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome.

William P Duggan, Manuela Salvucci, Batuhan Kisakol, Andreas U Lindner, Ian S Reynolds, Heiko Dussmann, Joanna Fay, Tony O'Grady, Daniel B Longley, Fiona Ginty and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Potential and application ofFrontiers in microbiology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

William P Duggan *Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.
Manuela Salvucci *Department of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Batuhan KisakolDepartment of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Andreas U LindnerDepartment of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Ian S ReynoldsDepartment of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.
Heiko DussmannDepartment of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Joanna FayRCSI Biobank, Royal College of Surgeons in Ireland, Dublin, Ireland.
Tony O'GradyRCSI Biobank, Royal College of Surgeons in Ireland, Dublin, Ireland.
Daniel B LongleyCentre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
Fiona GintyGE Research, Niskayuna, NY, 12309, USA.
Elizabeth Mc DonoughGE Research, Niskayuna, NY, 12309, USA.
Daniel J SladeDepartment of Biochemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
John P BurkeDepartment of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.
Jochen H M PrehnDepartment of Physiology and Medical Physicsand, RCSI Centre for Systems Medicine , Royal College of Surgeons in Ireland, Dublin 2, Ireland. Jprehn@rcsi.ie.ORCID http://orcid.org/0000-0003-3479-7794
Royal College of Surgeons in Ireland · IEGE Global Research (United States) · USBeaumont Hospital · IEQueen's University Belfast · GBVirginia Tech · US

Funding

Systems Modeling of Tumor Heterogeneity and Therapy Response in Colorectal CancerR01CA208179 · NCI · GENERAL ELECTRIC GLOBAL RESEARCH CTR · PI GINTY, FIONA · 2017 to 2021
$3.5M
NCI NIH HHS R01 CA208179
6 · The paper itself

Abstract

There is currently an urgent need to identify factors predictive of immunogenicity in colorectal cancer (CRC). Mucinous CRC is a distinct histological subtype of CRC, associated with a poor response to chemotherapy. Recent evidence suggests the commensal facultative anaerobe Fusobacterium may be especially prevalent in mucinous CRC. The objectives of this study were to assess the association of Fusobacterium abundance with immune cell composition and prognosis in mucinous CRC. Our study included two independent colorectal cancer patient cohorts, The Cancer Genome Atlas (TCGA) cohort, and a cohort of rectal cancers from the Beaumont RCSI Cancer Centre (BRCC). Multiplexed immunofluorescence staining of a tumour microarray (TMA) from the BRCC cohort was undertaken using Cell DIVE technology. Our cohorts included 87 cases (13.3%) of mucinous and 565 cases (86.7%) of non-mucinous CRC. Mucinous CRC in the TCGA dataset was associated with an increased proportion of CD8 + lymphocytes (p = 0.018), regulatory T-cells (p = 0.001) and M2 macrophages (p = 0.001). In the BRCC cohort, mucinous RC was associated with enhanced CD8 + lymphocyte (p = 0.022), regulatory T-cell (p = 0.047), and B-cell (p = 0.025) counts. High Fusobacterium abundance was associated with an increased proportion of CD4 + lymphocytes (p = 0.031) and M1 macrophages (p = 0.006), whilst M2 macrophages (p = 0.043) were under-represented in this cohort. Patients with increased Fusobacterium relative abundance in our mucinous CRC TCGA cohort tended to have better clinical outcomes (DSS: likelihood ratio p = 0.04, logrank p = 0.052). Fusobacterium abundance may be associated with improved outcomes in mucinous CRC, possibly due to a modulatory effect on the host immune response. KEY MESSAGES: • Increased Fusobacterium relative abundance was not found to be associated with microsatellite instability in mucinous CRC. • Increased Fusobacterium relative abundance was associated with an M2/M1 macrophage switch, which is especially significant in mucinous CRC, where M2 macrophages are overexpressed. • Increased Fusobacterium relative abundance was associated with a significant improvement in disease specific survival in mucinous CRC. • Our findings were validated at a protein level within our own in house mucinous and non-mucinous rectal cancer cohorts.

Indexed as

Colorectal NeoplasmsRectal NeoplasmsFusobacteriumHumansMacrophagesMicrosatellite InstabilityFusobacteriumMicrosatellite instabilityMucinous colorectal cancer

Identifiers

PMID37171483
PMCPMC10300184
OpenAlexW4376224938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.